vs

Side-by-side financial comparison of EQUITY BANCSHARES INC (EQBK) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

EQUITY BANCSHARES INC is the larger business by last-quarter revenue ($63.5M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). EQUITY BANCSHARES INC runs the higher net margin — 34.8% vs -4.8%, a 39.5% gap on every dollar of revenue. On growth, EQUITY BANCSHARES INC posted the faster year-over-year revenue change (28.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $38.1M). Over the past eight quarters, EQUITY BANCSHARES INC's revenue compounded faster (6.6% CAGR vs -20.2%).

Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

EQBK vs IRWD — Head-to-Head

Bigger by revenue
EQBK
EQBK
1.3× larger
EQBK
$63.5M
$47.7M
IRWD
Growing faster (revenue YoY)
EQBK
EQBK
+75.7% gap
EQBK
28.4%
-47.3%
IRWD
Higher net margin
EQBK
EQBK
39.5% more per $
EQBK
34.8%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$36.5M more FCF
IRWD
$74.6M
$38.1M
EQBK
Faster 2-yr revenue CAGR
EQBK
EQBK
Annualised
EQBK
6.6%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EQBK
EQBK
IRWD
IRWD
Revenue
$63.5M
$47.7M
Net Profit
$22.1M
$-2.3M
Gross Margin
Operating Margin
41.7%
14.3%
Net Margin
34.8%
-4.8%
Revenue YoY
28.4%
-47.3%
Net Profit YoY
30.0%
-200.9%
EPS (diluted)
$1.07
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EQBK
EQBK
IRWD
IRWD
Q4 25
$63.5M
$47.7M
Q3 25
$18.0M
$122.1M
Q2 25
$58.4M
$85.2M
Q1 25
$60.6M
$41.1M
Q4 24
$58.3M
$90.5M
Q3 24
$55.3M
$91.6M
Q2 24
$55.4M
$94.4M
Q1 24
$55.9M
$74.9M
Net Profit
EQBK
EQBK
IRWD
IRWD
Q4 25
$22.1M
$-2.3M
Q3 25
$-29.7M
$40.1M
Q2 25
$15.3M
$23.6M
Q1 25
$15.0M
$-37.4M
Q4 24
$17.0M
$2.3M
Q3 24
$19.9M
$3.6M
Q2 24
$11.7M
$-860.0K
Q1 24
$14.1M
$-4.2M
Operating Margin
EQBK
EQBK
IRWD
IRWD
Q4 25
41.7%
14.3%
Q3 25
-207.2%
61.8%
Q2 25
31.5%
53.2%
Q1 25
31.1%
-70.7%
Q4 24
35.0%
34.8%
Q3 24
43.1%
28.0%
Q2 24
29.4%
26.5%
Q1 24
31.8%
14.7%
Net Margin
EQBK
EQBK
IRWD
IRWD
Q4 25
34.8%
-4.8%
Q3 25
-164.7%
32.8%
Q2 25
26.1%
27.7%
Q1 25
24.8%
-90.9%
Q4 24
29.1%
2.5%
Q3 24
35.9%
4.0%
Q2 24
21.1%
-0.9%
Q1 24
25.2%
-5.6%
EPS (diluted)
EQBK
EQBK
IRWD
IRWD
Q4 25
$1.07
$0.01
Q3 25
$-1.55
$0.23
Q2 25
$0.86
$0.14
Q1 25
$0.85
$-0.23
Q4 24
$1.06
$0.03
Q3 24
$1.28
$0.02
Q2 24
$0.76
$-0.01
Q1 24
$0.90
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EQBK
EQBK
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$443.2M
Stockholders' EquityBook value
$732.1M
$-261.8M
Total Assets
$6.4B
$396.9M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EQBK
EQBK
IRWD
IRWD
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
EQBK
EQBK
IRWD
IRWD
Q4 25
$443.2M
Q3 25
$486.9M
$199.5M
Q2 25
$448.4M
$199.3M
Q1 25
$376.9M
$199.2M
Q4 24
$312.8M
$199.0M
Q3 24
$437.5M
$198.8M
Q2 24
$391.7M
$198.6M
Q1 24
$367.1M
$398.3M
Stockholders' Equity
EQBK
EQBK
IRWD
IRWD
Q4 25
$732.1M
$-261.8M
Q3 25
$711.9M
$-264.2M
Q2 25
$635.6M
$-308.2M
Q1 25
$617.3M
$-334.1M
Q4 24
$592.9M
$-301.3M
Q3 24
$504.0M
$-311.3M
Q2 24
$461.4M
$-321.7M
Q1 24
$456.8M
$-330.5M
Total Assets
EQBK
EQBK
IRWD
IRWD
Q4 25
$6.4B
$396.9M
Q3 25
$6.4B
$396.1M
Q2 25
$5.4B
$342.9M
Q1 25
$5.4B
$327.2M
Q4 24
$5.3B
$350.9M
Q3 24
$5.4B
$389.5M
Q2 24
$5.2B
$395.6M
Q1 24
$5.2B
$438.8M
Debt / Equity
EQBK
EQBK
IRWD
IRWD
Q4 25
0.61×
Q3 25
0.68×
Q2 25
0.71×
Q1 25
0.61×
Q4 24
0.53×
Q3 24
0.87×
Q2 24
0.85×
Q1 24
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EQBK
EQBK
IRWD
IRWD
Operating Cash FlowLast quarter
$51.4M
$74.6M
Free Cash FlowOCF − Capex
$38.1M
$74.6M
FCF MarginFCF / Revenue
60.0%
156.3%
Capex IntensityCapex / Revenue
20.9%
0.0%
Cash ConversionOCF / Net Profit
2.33×
TTM Free Cash FlowTrailing 4 quarters
$88.8M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EQBK
EQBK
IRWD
IRWD
Q4 25
$51.4M
$74.6M
Q3 25
$8.5M
$47.6M
Q2 25
$28.3M
$-15.1M
Q1 25
$21.7M
$20.0M
Q4 24
$73.8M
$15.2M
Q3 24
$23.5M
$9.9M
Q2 24
$16.0M
$33.5M
Q1 24
$12.6M
$45.0M
Free Cash Flow
EQBK
EQBK
IRWD
IRWD
Q4 25
$38.1M
$74.6M
Q3 25
$4.5M
$47.6M
Q2 25
$26.0M
$-15.1M
Q1 25
$20.2M
$19.9M
Q4 24
$65.4M
Q3 24
$19.7M
$9.9M
Q2 24
$15.2M
$33.4M
Q1 24
$10.6M
$44.9M
FCF Margin
EQBK
EQBK
IRWD
IRWD
Q4 25
60.0%
156.3%
Q3 25
24.7%
39.0%
Q2 25
44.5%
-17.7%
Q1 25
33.3%
48.4%
Q4 24
112.1%
Q3 24
35.6%
10.8%
Q2 24
27.4%
35.4%
Q1 24
19.0%
60.0%
Capex Intensity
EQBK
EQBK
IRWD
IRWD
Q4 25
20.9%
0.0%
Q3 25
22.3%
0.0%
Q2 25
3.9%
0.0%
Q1 25
2.4%
0.1%
Q4 24
14.6%
0.0%
Q3 24
6.8%
0.0%
Q2 24
1.5%
0.1%
Q1 24
3.6%
0.1%
Cash Conversion
EQBK
EQBK
IRWD
IRWD
Q4 25
2.33×
Q3 25
1.19×
Q2 25
1.85×
-0.64×
Q1 25
1.44×
Q4 24
4.35×
6.74×
Q3 24
1.18×
2.71×
Q2 24
1.37×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons